ACM
EXAS

Accipiter Capital Management’s Exact Sciences EXAS Stock Holding History

Accipiter Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-78,156
Closed -$721K – 11
2015
Q4 		$721K Buy
+78,156
New +$727K 0.39% 14

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Accipiter Capital Management's EXAS Position: Q1 2016 in Review

Accipiter Capital Management sold out of Exact Sciences (EXAS) in Q1 2016, closing a stake of 78,156 shares — an estimated $721K sold.

Accipiter Capital Management first reported a position in EXAS in Q4 2015 and held it in 1 quarter. The position peaked at $721K in Q4 2015. 167 funds tracked by Wall St. Rank hold EXAS as of Q1 2016.

  • Accipiter Capital Management reported no remaining Exact Sciences position as of Q1 2016 after selling out during the quarter.
  • Accipiter Capital Management sold 78,156 Exact Sciences shares in Q1 2016, an estimated $721K.
  • Accipiter Capital Management first reported a position in Exact Sciences in Q4 2015 and held it in 1 quarter.
  • Accipiter Capital Management's Exact Sciences position peaked at $721K in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2016.

Based on Accipiter Capital Management's 13F filing for Q1 2016, filed 16 May 2016.